Deep Tech Proyects 15 October, 2024

Makby: 3D bioprinting software for regenerative medicine

Project fact sheet

Vertical: Customised health

Project description

Makby’s goal is to offer a platform/software for next-generation 3D bioprinting. Its user-friendly and intuitive interface facilitates the design and integration of 2D and 3D constructions, by combining different printing and biomaterial technologies harmoniously.

The platform will help to improve the bioprinting of complex biological constructs, thus resulting in a technological advance in the area of artificial tissue engineering, which is currently stalled. The software is already deployed in different national and international universities.

Tagline: Don’t let software be an obstacle for your research. Makby, the gold standard for 3D bioprinting software.

Financing needs: Around €300,000 The money will be used to cover the costs of the first two years, which include validating and marketing the software.

 

Technology Readiness Level TRL-8
Venture Readiness Level Traction - BRL5

Market

The Makby market covers three different segments: the academic groups working in cutting-edge areas in regenerative medicine, the contract research organisations (CRO) that offer services to pharmaceutical companies to develop drugs, and the pharmaceuticals themselves.

Technology tags

3d Technologies artificial intelligence nanotech machine learning Regenerative medicine

Business model

Client B2C / B2B
Revenue model Sale of Software / Software licences

Project needs

Looking to connect with... Investors, profile search
See job offer profile

Promoted by

Makby

Are you interested in high-tech projects capable of generating greater market impact?

Fill in this form and we will contact you if you want to take part in this initiative – either by contributing technology assets or if you are a talent promoter capable of turning them into business projects.

Related news

NeoSegMed: AI-powered software for biomedical image segmentation and implant planning
30/09/2026 Entrepreneurship

NeoSegMed: AI-powered software for biomedical image segmentation and implant planning

Basque Tek Ventures supports the work behind NeoSegMed, an AI software solution that transforms biomedical images into 3D models and helps plan dental implants and personalized surgical guides.

SORPMETRICS: We make adsorption visible
30/09/2026 Entrepreneurship

SORPMETRICS: We make adsorption visible

Basque Tek Ventures supports Sorpmetrics, a project developing devices that directly measure how much of a substance a porous material captures from a liquid, without destroying the sample.

XRAI: Cost and environmental impact reduction by decreasing the number of false defects through the use of AI in inspections
30/09/2026 Entrepreneurship

XRAI: Cost and environmental impact reduction by decreasing the number of false defects through the use of AI in inspections

Basque Tek Ventures supports XRAI in applying AI to industrial inspection to classify defects detected in parts and reduce the manual review of potential non-conformities.

BIOND: Biomimetic Bioreactors for Cell Culture
30/09/2026 Entrepreneurship

BIOND: Biomimetic Bioreactors for Cell Culture

Basque Tek Ventures supports BIOND's project which combines biochemical and biophysical stimuli to study cell behavior with unprecedented realism, accelerating drug discovery and enabling more effective, personalized treatments for each patient.

BACKPACKED-ANTIBODIES: increasing the therapeutic payload and improves efficacy and tolerability compared to ADCs
10/08/2026 Entrepreneurship

BACKPACKED-ANTIBODIES: increasing the therapeutic payload and improves efficacy and tolerability compared to ADCs

Basque Tek Ventures supports B-Ab’s project, which develops an antibody platform with lipid nanodiscs to carry larger therapeutic payloads and combine different drugs.

HEVEA 3D: 3D printing of real elastomers without moulds: functional parts in a matter of days
27/07/2026 Entrepreneurship

HEVEA 3D: 3D printing of real elastomers without moulds: functional parts in a matter of days

Basque Tek Ventures supports Hevea3D’s project, which produces functional elastomeric parts through latex 3D printing, without the need for molds and with shorter development times.

FURANTEK: Cost-effective and scalable bio-based PDO to capture a high-value chemical market
20/07/2026 Entrepreneurship

FURANTEK: Cost-effective and scalable bio-based PDO to capture a high-value chemical market

Basque Tek Ventures supports this initiative, which develops cost-effective, scalable bio-based PDO technology to capture a high-value chemical market.

SEBALEX THERAPEUTICS: Therapeutic antibodies for prostate cancer and pulmonary fibrosis
06/07/2026 Entrepreneurship

SEBALEX THERAPEUTICS: Therapeutic antibodies for prostate cancer and pulmonary fibrosis

Basque Tek Ventures supports SebAleX Therapeutics’ project, which develops antibodies targeting WNT11 with the potential to treat certain types of cancer and fibrotic diseases.

NOVANANO MEDICAL: Implant modification to prevent the formation of bacterial biofilms
29/06/2026 Entrepreneurship

NOVANANO MEDICAL: Implant modification to prevent the formation of bacterial biofilms

Basque Tek Ventures supports Novanano Medical’s project, which develops nanoscale surface treatments and coatings for medical implants, reducing bacterial adhesion and promoting implant integration with surrounding tissues.

BIOBLUE: The next generation of biodegradable FADs for tuna fishing
22/06/2026 Entrepreneurship

BIOBLUE: The next generation of biodegradable FADs for tuna fishing

Bioblue’s project develops fish aggregating devices for tuna fishing using bio-based and biodegradable materials that remain functional during use and degrade in the sea.

Go to the blog section

Follow us

Specialized channels and daily news on our social profiles.